drugset / Trial / NCT06095986
A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of this study is to Evaluate the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Patients with Primary Sclerosing Cholangitis
Timeline
- Start
- 2025-06
- Primary completion
- 2026-09
- Completion
- 2027-12
Outcome
Outcome not reported
Stopped: “Operational and clinical reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aramchol | Other / unclassified | — | — |